Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats

Toxicologic Pathology

Volumn 40, Issue 7, 2012, Pages 1049-1062

  Vinken, Petra ^a   Starckx, Sofie ^a   Barale Thomas, Erio ^a   Looszova, Adriana ^a   Sonee, Manisha ^b   Goeminne, Nick ^a   Versmissen, Loes ^a   Buyens, Kristel ^a   Lampo, Ann ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

biomarker; cisplatin; clusterin; immunohistochemistry; Kim 1; nephrotoxicity; rat; urinalysis

Indexed keywords

CISPLATIN; CLUSTERIN; CREATININE; KIDNEY INJURY MOLECULE 1; OSTEOPONTIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHILIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; KIDNEY PROXIMAL TUBULE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BODY WEIGHT; CISPLATIN; CLUSTERIN; DISEASE MODELS, ANIMAL; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MEMBRANE PROTEINS; ORGAN SIZE; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS; URINALYSIS;

RATTUS;

EID: 84867093493     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312444765     Document Type: Article

References (28)

1. Journal of the American Veterinary Medical Association. 2007: 669-96.
2. Baines R. J., Brunskill N. J.. Tubular toxicity of proteinuria. Nature Reviews Nephrology. 2010 ; 7: 177-80
3. 1991, October 18 :
4. Burry R. W.. Controls for immunocytochemistry: An update. Journal of Histochemstry & Cytochemistry. 2011 ; 59: 6-12
5. de Borst M. H., van Timmeren M. M., Vaidya V. S., de Boer R. A., van Dalen M. B. A., Kramer A. B., Schuurs T. A., Bonventre J. V., Navis G., van Goor H.. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. American Journal of Physiology-Renal Physiology. 2007 ; 292: F313-20
6. Dieterle F., Marrer E., Suzuki E., Grenet O., Cordier A., Vonderscher J.. Monitoring kidney safety in drug development: Emerging technologies and their implications. Current Opinion in Drug Discovery & Development. 2008 ; 11: 60-71
7. Dieterle F., Perentes E., Cordier A., Roth D. R., Verdes P., Grenet O., Pantano S., Moulin P., Wahl D., Mahl A., End P., Staedtler F., Legay F., Carl K., Laurie D., Chibout S. D., Vonderscher J., Maurer G.. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nature Biotechnology. 2010 ; 28: 463-9
8. Dunn O. J.. Multiple comparisons using rank sums. Technometrics. 1964 ; 6: 241-52
9. 1986, November 24 :
10. European Medicines Agency (EMEA) (2008). Final conclusions on the pilot joint EMEA/FDA VXDS experience on qualification of nephrotoxicity biomarkers. Accessed January 9, 2012, athttp://www.ema.europa.eu/docs/en-GB/document- library/Regulatory-and-procedural-guideline/2009/10/WC500004205.pdf.
11. European Medicines Agency (EMA) (2010) Qualification opinion ILSI/HESI submission novel renal biomarkers for toxicity. Accessed January 9, 2012, athttp://www.ema.europa.eu/docs/en-GB/document-library/Regulatory-and- procedural-guideline/2010/11/WC500099359.pdf.
12. Food and Drug Administration (FDA) (2008). FDA, European Medicines Agency to consider additional test results when assessing new drug safety. FDA News Release. Accessed January 9, 2012, athttp://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/2008/ucm116911.htm.
13. Gautier J., Riefke B., Walter J., Kurth P., Mylecraine L., Guilpin V., Barlow N., Gury T., Hoffman D., Ennulat D., Schuster K., Harpur E., Pettit S.. Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with cisplatin. Toxicologic Pathology. 2010 ; 38: 943-56
14. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases. 2009 ; 54: 1012-24
15. Harpur E., Ennulat D., Hoffman D., Betton G., Gautier J. C., Riefke B., Bounous D., Schuster K., Beushausen S., Guffroy M., Shaw M., Lock E., Pettit S.. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of rat. Toxicological Sciences. 2011 ; 122: 235-52
16. Hoffmann D., Adler M., Vaidya V. S., Rached E., Mulrane L., Gallagher W. M., Callanan J. J., Gautier J. C., Matheis K., Staedtler F., Dieterle F., Brandenburg A., Sposny A., Hewitt P., Ellinger-Ziegelbauer H., Bonventre J. V., Dekant W., Mally A.. Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicological Sciences. 2010 ; 116: 8-22
17. Hoffmann D., Fuchs T. C., Henzler T., Matheis K. A., Herget T., Dekant W., Hewitt P., Mally A.. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology. 2010 ; 277: 49-58
18. Mather A., Pollock C.. Glucose handling by the kidney. Kidney International. 2011 ; 79 ((Suppl. 120)). S1-6
19. McDuffie J. E., Sablad M., Ma J., Snook S.. Urinary parameters predictive of cisplatin-induced acute renal injury in dogs. Cytokine. 2010 ; 52: 156-62
20. Ozer J. S., Dieterle F., Troth S., Perentes E., Cordier A., Verdes P., Staedtler F., Mahl A., Grenet O., Roth D. R., Wahl D., Legay F., Holder D., Erdos Z., Vlasakova K., Jin H., Yu Y., Muniappa N., Forest T., Clouse H. K., Reynolds S., Bailey W. J., Thudium D. T., Topper M. J., Skopek T. R., Sina J. F., Glaab W. E., Vonderscher J., Maurer G., Chibout S. D., Sistare F. D., Gerhold D. L.. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nature Biotechnology. 2010 ; 28: 486-94
21. Rouse R. L., Zhang J., Stewart S. R., Rosenzweig B. A., Espandiari P., Sadrieh N. K.. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney International. 2011 ; 79: 1186-97
22. Siegel S., Castellan N. J., Nonparametric Statistics for the Behavioral Sciences. 1988 ). Nonparametric Statistics for the Behavioral Sciences. 2nd Ed. McGraw-Hill International Editions, New York, NY. New York, NY: McGraw-Hill International Editions ; 1988 :
23. Tonomura Y., Tsuchiya N., Torii M., Uehara T.. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats. Toxicology. 2010 ; 273: 53-9
24. Vaidya V. S., Ozer J. S., Dieterle F., Collings F. B., Ramirez V., Troth S., Muniappa N., Thudium D., Gerhold D., Holder D. J., Bobadilla N. A., Marrer E., Perentes E., Cordier A., Vonderscher J., Maurer G., Goering P. L., Sistare F. D., Bonventre J. V. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nature Biotechnology. 2010 ; 28: 478-85
25. van Timmeren M. M., Bakker S. J. L., Vaidya V. S., Bailly V., Schuurs T. A., Damman J., Stegeman C. A., Bonventre J. V., van Goor H.. Tubular kidney injury molecule-1 in protein-overload nephropathy. American Journal of Physiology - Renal Physiology. 2006 ; 291: F456-64
26. Yang A., Traikovic D., Illanes O., Ramiro-Ibanez F.. Clinicopathological and tissue indicators of para-aminophenol nephrotoxicity in Sprague-Dawley rats. Toxicologic Pathology. 2007 ; 35: 521-32
27. Yao X., Panichpisal K., Kurtzman N., Nugent K.. Cisplatin nephrotoxicity: A review. American Journal of the Medical Sciences. 2007 ; 334: 115-24
28. Zhou Y., Vaidya V. S., Brown R. P., Zhang J., Rosenzweig B. A., Thompson K. L., Miller T. J., Bonventre J. V., Goering P. L.. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamycin, mercury, and chromium. Toxicological Sciences. 2008 ; 101: 159-70